![Shlomo Yanai, incoming president and CEO of Teva Pharmaceutical Industries, Ltd., takes part in the opening bell ceremonies at the NASDAQ in New York on February 21, 2007. (UPI Photo/Laura Cavanaugh Stock Shlomo Yanai, incoming president and CEO of Teva Pharmaceutical Industries, Ltd., takes part in the opening bell ceremonies at the NASDAQ in New York on February 21, 2007. (UPI Photo/Laura Cavanaugh Stock](https://c8.alamy.com/comp/TYHXYC/shlomo-yanai-incoming-president-and-ceo-of-teva-pharmaceutical-industries-ltd-takes-part-in-the-opening-bell-ceremonies-at-the-nasdaq-in-new-york-on-february-21-2007-upi-photolaura-cavanaugh-TYHXYC.jpg)
Shlomo Yanai, incoming president and CEO of Teva Pharmaceutical Industries, Ltd., takes part in the opening bell ceremonies at the NASDAQ in New York on February 21, 2007. (UPI Photo/Laura Cavanaugh Stock
![Mexico's social security agency sues Israel's Teva for allegedly bribing doctors - Business - Haaretz.com Mexico's social security agency sues Israel's Teva for allegedly bribing doctors - Business - Haaretz.com](https://img.haarets.co.il/img/1.9396672/1876432584.jpg?precrop=1411,1411,x551,y56&width=1200&height=1200)
Mexico's social security agency sues Israel's Teva for allegedly bribing doctors - Business - Haaretz.com
![Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too | FiercePharma Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too | FiercePharma](https://qtxasset.com/fiercepharma/1585082026/K%C3%A5re_Schultz.jpg/K%C3%A5re_Schultz.jpg?VersionId=Sip0eyB6sFNEjxw_3RP0JbV37_WsIdJ3)
Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too | FiercePharma
![Incoming Teva CEO Jeremy Levin (front) sits with Teva Chairman Phillip Frost (C) and outgoing CEO Shlomo Yanai during a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the Incoming Teva CEO Jeremy Levin (front) sits with Teva Chairman Phillip Frost (C) and outgoing CEO Shlomo Yanai during a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the](https://c8.alamy.com/comp/2CYN7GA/incoming-teva-ceo-jeremy-levin-front-sits-with-teva-chairman-phillip-frost-c-and-outgoing-ceo-shlomo-yanai-during-a-news-conference-in-tel-aviv-january-2-2012-teva-pharmaceutical-industries-the-worlds-largest-generics-drugmaker-said-on-monday-that-yanai-would-step-down-as-president-and-chief-executive-officer-in-may-yanai-will-be-replaced-by-levin-a-former-senior-executive-at-bristol-myers-squibb-teva-said-in-a-statement-reutersnir-elias-israel-tags-business-health-drugs-society-2CYN7GA.jpg)
Incoming Teva CEO Jeremy Levin (front) sits with Teva Chairman Phillip Frost (C) and outgoing CEO Shlomo Yanai during a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the
![With 3K-plus Teva layoffs slated in Israel and labor protests brewing, top exec steps aside | FiercePharma With 3K-plus Teva layoffs slated in Israel and labor protests brewing, top exec steps aside | FiercePharma](https://qtxasset.com/fiercepharma/1513109220/teva1_1.jpg/teva1_1.jpg?VersionId=z7vczA0Nq92Do78bl1NDrrXCW1AhtBkE)